WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR March 2023 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: MARCH ISSUE PUBLISHED

    March 2024 Issue has been successfully launched on 1 March 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

A REVIEW ON TREATMENT PATTERN OF ANTIBIOTICS AND STEROIDS USAGE IN COVID-19 PATIENTS

Akhil Sulaiman*, A. Bharath Kumar, N. Rizwana, M. Mona Sree, P. Sirisha and S. Bhavani

ABSTRACT

Corona virus (COVID-19) pandemic due to the novel SARS Coronavirus (SARS-CoV-2) has resulted in a sudden, large and prolonged increase in hospitalizations of patients fulfilling the criteria for community-acquired pneumonia (CAP). SARS-CoV-2 can lead to a wide spectrum of disease, ranging from very mild symptoms of upper respiratory tract infection to life-threatening pneumonia. Corticosteroids are hormones that are naturally produced from the adrenal cortex and are involved in a variety of physiological processes, such as inflammatory regulation, stress, and immunological response, protein, and carbohydrate metabolism. As a result, corticosteroids are critical in the management of autoimmune, allergic, malignant, and many inflammatory disorders. In COVID-19-related severe acute respiratory syndrome, viral escape of cellular immune response and the cytokine storm is important in pathophysiology and clinical consequences. Dysregulation of cytokine and invasion of inflammatory myeloid cells results in lung inflammation and severe sequelae, such as acute respiratory distress syndrome, respiratory failure, sepsis, multi-organ failure, and death. Corticosteroids have significant anti-inflammatory and anti-fibrotic effects, which may play a role in reducing pulmonary inflammation, especially in severe pneumonia and in advanced stages of COVID-19 disease. The patient may be completely asymptomatic with a positive swab test, may present with a mild influenza-like illness or may present with serious symptoms that require hospitalisation. The effective vaccination, and oxygen therapy, antivirals, steroids, HCQS and antibiotics can minimize the COVID-19 clinical symptoms among affected patients.

[Full Text Article] [Download Certificate]